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2Summary
Owing to the complexity  of higher eukaryotic cells, a complete proteome is likely to be very difficult to
achieve. However, advantage can be taken of the cell compartmentalization to build organelle proteomes,
which can moreover be viewed as specialized tools to study specifically the biology and “physiology” of
the target organelle. Within this frame, we report here the construction of the human mitochondrial
proteome, using placenta as the source tissue. Protein identification was carried out mainly by peptide
mass fingerprinting. The optimization steps in 2D electrophoresis needed for proteome research are
discussed. However, the relative paucity of data concerning mitochondrial proteins is still the major
limiting factor in building the corresponding proteome, which should be a useful tool for researchers
working on human mitochondria and their deficiencies.
Abbreviations
BisTris: N-N bis (hydroxyethyl) N-N-N tris (hydroxymethyl) aminomethane; CHAPS: 3[ (3-
cholamidopropyl) dimethylammonio] propane sulfonate; CID: Collision-Induced Degradation;  ECL:
enhanced chemiluminescence; IEF: Isoelectric focusing; IPG: IEF in immobilized pH gradients; IPG-
DALT: 2D electrophoresis with IEF in  immobilized pH gradient in the first dimension and SDS PAGE in
the second dimension;   MALDI: Matrix Assisted Laser Desorption and Ionization; MS: mass
spectrometry; PAGE: polyacrylamide gel electrophoresis; PBS: phosphate buffered saline; PSD: post-
source decay; TOF: time of flight
31. Introduction
The classical approach in proteomics couples 2D electrophoresis with post-gel identification by mass
spectrometry. While this technique has proved quite efficient, as shown by the numerous databases
available to date (see the Expasy server at www.expasy.ch/ch2d/2d-index.html for a partial index of such
databases), its limitations are now well described [1]. Among those limitations, three are felt with
increasing acuity: (i) the difficulty in the analysis of basic and large proteins [2], (ii) the under-
representation of membrane proteins [3] and (iii) the poor analysis of low-abundance proteins. The latter
limitation is due both to the high dynamic range of protein expression in living cells and to the relative
lack in resolution and capacity of 2D gels. While the latest techniques used for 2D gels seem to be able to
cope with the proteome complexity of prokaryotes [4, 5], they still do not match with the complexity
encountered in multicellular eukaryotes. One way to circumvent this difficulty is to cut the complex
sample represented by the eukaryotic cell into several less complex samples. This can be done on
chemical criteria (e.g. narrow pH gradients, as in [2] and [5]) but also on biochemical criteria, using the
compartimentalization of eukaryotic cells. This latter approach adds valuable localization and functional
information  and is therefore quite attractive. One of the first example of such subcellular proteomes has
been made on mitochondria [6], but other, more recent examples have been shown on lysosomes [7],
golgi [8] or chloroplasts [9].
While this work on organelle proteomes has demonstrated its interest both on the functional point of view
and its ability to deal with lower abundance proteins, it is becoming apparent that the proteome coverage is
still far from perfect. In addition to the technical limitations for basic, large or hydrophobic proteins, the
dynamic range is still not sufficient and further fractionation of the organelle content has been proposed
[10]. However, these fractionation techniques require massive amounts of mitochondria, which are not
easily available either from patient biopsies or even from model cell culture systems [11], [12]. This is
why we chose to use only more straightforward proteomic approaches.
However, proteomic techniques are still evolving, and some of the above-mentioned limitations have been
addressed by dedicated gradients for basic proteins [13], improved solubilization cocktails, detection
methods or mass spectrometry methods or apparatus. Keeping to the mitochondrial example, we have
therefore decided to investigate how these technical improvements can help in improving the coverage of
organelle proteomes.
2. Materials and methods
2.1. Isolation of placental mitochondria
The method of preparation of mitochondria from human placenta was modified from Ausenda and
Chomyn  [14]. Human placenta were obtained from the local hospital (Grenoble) within 1 h of delivery
4and transported in ice to the laboratory. All manipulations were performed at 4°C unless otherwise stated.
The tissue mostly freed of membrane and connective tissue was cut in small pieces and washed extensively
by 2 L of 10 mM phosphate-buffered saline pH 7.4 (138mM NaCl, 2,7 mM KCl). The rinsed and drained
tissue was then processed for 1 min with 500 ml homogeneization buffer (0.25 M sucrose, 0.15 M KCl,
10 mM Tris-Cl, pH 7.5, 1 mM EDTA, 0.5% fatty acid-free BSA) in a Waring blender at low speed.
Homogenate was centrifuged 10 min at 800g. The collected supernatant was filtered through layers of
cheesecloth and centrifuged 15 min at 12000g. The resulting pellet was resuspended in 100 ml of  0.225
M sucrose, 0.075 M mannitol, 10 mM Tris-Cl, pH 7.5, 1 mM EDTA) and centrifuged 10 min at 1000g.
The mitochondria were then pelleted by centrifuging the 1000g supernatant at 12000g for 15 min,
resuspended in the same buffer and washed twice. Mitochondria were stored in liquid nitrogen.
2.2. Sample preparation for 2D gels.
The mitochondrial suspension was diluted directly fivefold in a concentrated lysis solution containing 9M
urea, 2.5M thiourea, 5% (w/v) CHAPS, 12.5 mM DTT and 0.5% (w/v) carrier ampholytes (Pharmalytes 3-
10) [15], or in some instances in a solution containing other detergents [16] . After 1 hour at room
temperature, the solution was directly used for in gel sample-rehydration.
2.3. Immobilized pH gradient focusing
2.3.1. Gel casting
The Immobiline concentrations used to generate the pH gradients (mean buffering power = 3 mequiv.l-
1.pH-1) were calculated according to published recipes [17]. The pH 5.5 to 12 gradient is interpolated
from the previously described 4-12 gradient [13].  Linear pH gradients with plateaus were used in all cases
[18]. Gels were cast at 4.5%T, and polymerized at 50°C.
2.3.2. IPG strip rehydration, running and equilibration
4mm wide IPG strips were cut from the dry plate with the use of a paper cutter. The protein solution was
added to the denaturing solution (4% (w/v) CHAPS, 0.5% (v/v) Triton X100, 0.4% (w/v) carrier
ampholytes (Pharmalytes 3-10), 10mM DTT, 2M thiourea and 7M urea) to a final volume of 400 µl
(sample loading with cup) to 600 µl (sample loading by rehydration). In some cases, a solution containing
other detergents than CHAPS was used.  
The strips were run on a Dry-strip kit according to the manufacturer's instructions with the previously
described modifications [18]. The entire set-up was covered with low viscosity silicon or paraffin oil, and
the temperature set at 22°C with a circulating water bath.
Migration was carried out for a total of 50 to 60 kVh [15].
2.4. Equilibration, SDS dimension and staining
5After the IEF run, the oil was poured off, and the strips equilibrated while in place in the running setup, as
previously described [19]. The strips were then sealed on the top of the 1.5mm thick second dimension gel
(Bio-Rad vertical system) with the help of 1% low-melting agarose in 0.2% SDS, 0.15M BisTris-0.1M
HCl buffer supplemented with bromophenol blue as a tracking dye.
SDS-PAGE was carried out at constant power (15W per gel) with cooling at 10°C, until the tracking dye
reached the bottom of the gel. Gels were stained with silver [20]. Basic gels were stained with an
ammoniacal silver staining with either a first fixation in 4% formaldehyde-25% ethanol [21] or fixation in
0.05% naphthalene disulfonate in 5% acetic acid and 30% ethanol [6]. Preparative gels for spot excision
for mass spectrometry were generally stained with a home-made fluorescent ruthenium complex [22].
2.5. In-gel protein digestion and MALDI-MS
Stained proteins spots or bands were excised (on a UV table for fluorescent detection). Silver-stained gel
pieces were destained with ferricyanide-thiosulfate [23]. Gel pieces were then shrunk in 1 ml of 50%
ethanol for 2 hours, and stored at -20°C.
Each gel slice was cut into small pieces with a scalpel, washed with 100 µl of 25 mM NH4HCO3, agitated
for 8 min with a Vortex mixer. After settling of the gel pieces, the supernatant was removed. Gel pieces
were dehydrated with 100 µl of acetonitrile for 8 min. This operation was repeated twice. Gel pieces were
completely dried with a Speed Vac (15 min.) before reduction-alkylation. Gel pieces were covered with
100 µl of 10 mM DTT in 25 mM NH4HCO3 and the reaction was left to proceed at 57°C for 1 hour. The
supernatant was removed, 100 µl of 55 mM iodoacetamide in 25 mM NH4HCO3 were added and reaction
was left in the dark at room temperature for 1 hour. The supernatant was removed and the washing
procedure with 100 µl of NH4HCO3 and acetonitrile was repeated three times. Gel pieces were completely
dried with a Speed Vac before tryptic digestion. The dried gel volume was evaluated and three volumes of
trypsin (12.5 ng/µl) in 25 mM NH4HCO3 (freshly diluted) were added. The digestion was performed at
35°C overnight. The gel pieces were centrifuged and 5 µl of 25% H2O/70% Acetonitrile/5% HCOOH
were added. The mixture was sonicated for 5 min. and centrifuged. The supernatant was recovered and the
operation was repeated once. The supernatant volume was reduced under nitrogen flow to 4 µl, 1 µl of
H2O/5% HCOOH were added and 0.5 µl  of the mix were used for MALDI-TOF analysis.
Mass measurement were carried out on a Bruker BIFLEX™ MALDI-TOF equipped with the SCOUT™
High Resolution Optics with X-Y multisample probe and gridless reflector. This instrument was used at a
maximum accelerating potential of 20 kV and was operated in reflector mode. A saturated solution of
α−cyano-4-hydroxycinnamic acid in acetone was used as a matrix. A first layer of fine matrix crystals was
obtained by spreading and fast evaporation of 0.5 µl of matrix solution. On this fine layer of crystals, a
droplet of 0.5 µl of aqueous HCOOH (5%) solution was deposited. Afterwards, 0.5 µl of sample solution
was added and a second 0.2 µl droplet of saturated matrix solution (in 50% H2O/50% acetonitrile) was
added. The preparation was dried under vacuum. The sample was washed one to three times by applying
61µl of aqueous HCOOH (5 %) solution on the target and then flushed after a few seconds. Internal
calibration is performed with Angiotensin 1046.542 Da, Substance P 1347.736 Da, Bombesin 1620.807
Da, and ACTH 2465.199 Da.
Monoisotopic peptide masses were assigned and used for databases searches. The MASCOT program
was used to database searching [24]. All proteins present in NCBInr were taken into account without any
species, pI and Mr restrictions. The peptide mass error was limited to 100 ppm, 1 missed cleavage might be
accepted and no AA substitutions were allowed. The statistical tools provided by MASCOT as well as the
species of the candidate proteins returned by MASCOT were used for result interpretation and protein
identification. For example, MOWSE score greater than 75 only were considered as significant, and at
least 3 matching peptides were necessary for a positive identification. This rather low number was dictated
by our need to identify low molecular weight proteins.
  
3. Results
3.1. 2D electrophoresis
Immobilized pH gradients were selected for their intrinsic reproducibility and loading capacity. In
addition, they should allow analysis of basic proteins [13]. To this purpose, we decided to complement
our standard 4-8 map with basic proteins. To this purpose, we used either wide pH gradients [25] or more
dedicated gradients. As the very basic pH gradients (8-12, 9-12) seem rather difficult to use [26], we
decided to cast a pH  5.5 to 12 pH gradient, starting from the published 4-12 pH gradient [13]. For this
gradient, as well as for the other basic ones, anodic cup loading proved much more efficient than in gel
sample rehydration [25, 27]. Oppositely, the focusing time was found not to be critical, so that we used
our standard 24 hours migration, resulting in ca. 60 kVh focusing, for 4-8, 3-12 and 5.5-12 gradients. The
optimal resolution was reached by using a 4-8 and a 5.5-12 pH gradient. As shown on figure 1, the pH 3-
12 gradient led to important compression, and therefore low resolution, in the acidic part. The basic part of
this gradient showed quite nice focusing and spot definition, but the actual pIs of the proteins displayed
on this gradient (e.g. MDHM or POR1) did not extend above pH 9, while it should extend at least to pH
11. Therefore, many basic mitochondrial proteins are missing on those wide pH gradients (compare
figure 1 and figure 3). Oppositely, the 5.5-12 gradient showed greater streaking, but improved resolution
and protein display above pH 9.
3.2. Reference map analysis and protein identifications
The Melanie software detected ca. 1500 spots on the silver-stained acidic reference map gel, i.e. in a pI 4
to 8 and a Mr 10-200 kDa range. 1250 spots were detected on the basic reference gel (pH 5.5-12 range).
The dynamic range varied from 30 to 7500 arbitrary detection units, for a total integrated density of
7350000. This means that proteins present at 0.01 % of the initial input can be visualized (see figure 3).
However, the less abundant proteins identified to date by general  methods (i.e. neither comigration nor
blotting) represent 0.03 % of the original sample, while the majority of medium spots identified are in the
0.1-0.5% range.
The reference 2D map of human placenta mitochondria and the current state of the corresponding
proteome are shown on figures 2 and 3 and Tables 1 and 2. Spot identification was easy by MALDI-TOF
above 15-20 kda. Below this mass, a low number of peptides was often encountered, which precluded
secure protein identification. As an example, COX Va, Vb and VIa could be identified by MALDI TOF,
while ATP synthase δ and thioredoxin required MS/MS for safe identification [6, 11]. However, it must
be mentioned that basic proteins, richer in lysine and arginine than their acidic counterparts, were much
easier to identify with MALDI, even with low molecular weight proteins. An example is shown in Figure
4 with the MALDI spectrum of the NUML/MLRQ subunit of complex 1. For this small, basic protein, 4
peptides were obtained, which is a small number, but the sequence coverage is over 70% (see table 1),
which affords secure protein identification. Conversely, mitochondrial thioredoxin, which is a larger but
more acidic protein, only gave 2 tryptic peptides which did not provide safe protein identification.
4. Discussion
4.1.  Protein detection optimization.
As soon as peptides need to be extracted from the 2D gel for the purposes of spot identification, the
detection method needs to be optimized. For example, even with glutaraldehyde-free protocols, which are
mass spectrometry compatible, silver staining results in peptide losses and therefore decreased
identification efficiency [28]. For this reason, many groups use colloidal Coomassie blue staining at least
for micropreparative work. In some instances (e.g. [4]) this method is the only detection method used.
However, mitochondrial proteins are much less easy to obtain than bacterial proteins, so that such an
approach cannot be used in our case. In addition, the detection threshold of colloidal Coomassie blue is
rather high [29]. This ensures that enough protein is present for mass spectrometry, but this conversely
requires very high loads to analyze minor proteins. Moreover, the improvements in identification methods
allow to identify proteins at levels which are below the colloidal Coomassie blue detection threshold. For
this reason, we used zinc-imidazole staining for micropreparative work and silver staining for the
analytical work in our previous study [6]. However, zinc-staining provides very low contrast, resulting in
major difficulties for spot assignment and excision. We therefore decided to use a more user-friendly
method for our micropreparative work. Fluorescent detection, using either commercial probes [30, 31], or
home-made ones [22], is known to provide sensitive detection and low interference with mass
spectrometry. We decided to use a home-made ruthenium complex for our micropreparative work, as it
combines high sensitivity, low cost, minimal interference with mass spectrometry, and easy excitation with
8a UV table for spot excision [22].
Analytical detection was carried out with silver staining, using a silver nitrate method [20] for acidic and
neutral proteins (i.e. 4-8 and 3-12 gradients) and  ammoniacal silver methods [6], for alkaline proteins
(i.e. 5.5-12 gradients). It must be emphasized here that some basic proteins stain nicely with ammoniacal
silver staining with formaldehyde fixation but are hardly detectable with any other method [21]. The
ADP-ATP carrier, a major inner membrane protein, is a typical example of such proteins.
4.2. Scope of analysis
(i) The classical problem, when dealing with an organelle proteome, is the one of the contamination by
other cell components. This cannot be ruled out, whatever the purification method of the organelle may be.
A typical example in the case of placenta mitochondria is shown by the choriomammotropin (PLL). This
protein is a major secreted protein, and is found at high levels in mitochondrial preparations (see figure 2).
This is probably due to the fact that the corresponding secretion granules have a rather large size and a
density close to that of mitochondria. The corresponding spot is of course absent when mitochondria
from other origins (e.g. cultured cells) are analyzed. However, as they represent only 10% of the protein
content of the cells, the overall protein yield is low. This makes the use of cultured cells critical to obtain
the protein amounts still needed for reference proteome work, while they can be invaluable models in other
aspects [11, 12]. Thus, for reference purposes, it is much better to start from tissues, and this explains why
bovine heart has been used for years in mitochondrion research. Another obvious contaminant is the BSA
used during the initial isolation stages of the mitochondria, which is found in the 2D maps, even if the
mitochondria are washed several times in BSA-free buffer. The other contaminants observed in our
mitochondrial proteome may be linked to the mitochondrion-cytosol interface. This is obviously the case
for cytoskeletal proteins (e.g. actin and Rho protein) which probably act as positioners for the
mitochondria within the cell and are therefore linked to the surface of the mitochondria. However, typical
ER proteins are also encountered, such as a diaphorase isoform, disulfide isomerases and some
chaperones (grp78 and 94). This shows a cross contamination of our mitochondrial preparations with ER.
Such cross contaminations greatly vary from one source to another, and are for example much less
pronounced with heart or liver tissue than with placenta. However, when dealing with human tissues,
ethical issues apply. This is why we chose to use placenta as a starting tissue, despite the fact that placental
mitochondria exhibit greater contamination than heart mitochondria, as shown here and in previous work
[6]. We tried to remove these non-mitochondrial contaminants by using density or viscosity gradients, but
the gain in purity was marginal, while the yield decreased severely.
 (ii) Several protein spots gave good spectra but no hits in the databases. This is most probably linked to
the rather low number of mitochondrial proteins described in the databases. A search in the Swiss-Prot
9database yielded only 311 entries of human mitochondrial proteins. This database coverage problem is
also examplified by the fact that peptide mass fingerprinting sometimes gives a hit for recently cloned
genes (e.g. Q9HBL7) for which very few functional data are available.
(iii) This problem is however attenuated by the fact that mitochondrial proteins seem to be very highly
conserved from one species to another. This is shown for example from the identification of ATPase
subunits or heat shock proteins . In such cases, the first hit is the correct protein, but the homologous
proteins from other species also give very high scores. This allows cross-species identification by peptide
mass fingerprinting with rather good confidence. This has been already described for mouse ATP
synthase beta [32], and is probably also the case in this study with the first description of a human
sideroflexin protein.
(iv) basic and small proteins
One of the problems associated with the analysis of mitochondrial proteins is that they are general more
basic than the standard cytosolic proteins. This was a major problem up  to the very last years. However,
the appearance of robust basic immobilized pH gradients [13] dramatically changed the situation and
allowed to display proteins with a pI up to 10 without major problems. The situation is still difficult above
pH 10, as shown by the absence of mitochondrial ribosomal proteins on our maps. However, in addition
of being very basic, mitochondrial ribosomal proteins are also very weakly abundant [33], which further
hampers their analysis in total mitochondrial extracts.
Mitochondria are also very rich in low-molecular weight (<10 kDa) proteins. This is the case for example
in the respiratory complexes. NADH ubiquinone oxidoreductase (respiratory complex I) is composed of
more than 40 subunits, and 7 are below 10 kDa. Quite often, these small proteins are also basic and
completely escaped from the analysis in our previous work. Despite the fact that they are quite difficult to
detect, we could analyze some of them, as examplified by the detection of the MLRQ, B17 and B18
subunits of complex I. The same holds true for ATP synthase, where only 2 subunits out of 13 were
detected in our previous work [6], while 6 subunits have been now identified on our 2D maps.
(v) membrane proteins
Membrane proteins are known to be a major issue in 2D PAGE-based proteomics [3]. This is
examplified by the fact that even not a single membrane proteins was described in our previous
mitochondrial proteome. This is fortunately no longer the case, thanks to significant advances in the
solubilization of hydrophobic proteins for 2D PAGE [16]. Thus, true membrane proteins can be seen in
the current proteome, even with basic pIs. It must be mentioned, however, that mitochondrial membrane
proteins belong to three different classes. The first class is the one of beta barrels proteins [3], which
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includes the porins (mitochondrial or bacterial). These  proteins are easily seen on 2D maps, even with
standard conditions [34], and are therefore easily detected on our maps. The second class is represented
by the respiratory complexes. In these complex protein assemblies, different subunits build the
membrane-embedded anchor and the mitochondrial matrix-protruding extension. A good example of this
situation is ATP synthase, which is made of a membrane-embedded Fo domain and a protruding F1
extension. Quite often, the membrane-embedded subunits are small and very hydrophobic, a poor
situation for 2D PAGE. However, we could detect some of the Fo subunits (ATP synthase e and g
chains). Many of these proteins are still missing to date (e.g. other Fo subunits and the ND1 to ND6
subunits of complex I), but further progress is still expected. The last class of mitochondrial membrane
proteins is made of  more classical, transmembrane helices-containing proteins, here again quite often
basic. Rather surprisingly, this class is the one which performs less in our system. For example, we could
not detect and analyze the glutamate-malate exchanger, the phosphate carrier etc..., which represent a
subclass of basic (pI ca. 10) medium-sized (30 kDa) proteins. We could however analyze two members
of this class. One is the ATP-ADP carrier, a very abundant member of this class and one other is very
likely to be sideroflexin, i.e. a putative iron or iron-related metabolite transporter [35]. This first successes
suggest that we may be close to be  able to handle these proteins, likely by further improvement through
the use of optimized detergent-chaotropes combinations. As previously described [3], the ratio between
the size of the protein and the number of transmembrane segments seems to be the key parameter. As a
positive example, mitofilin, which is a 100 kDa protein with a single predicted transmembrane segment
[36], is easily analyzed in our system (Figure 2). Although it is almost sure that some membrane proteins
will escape 2D PAGE-based proteomics, the improvements achieved in the last years (from 0 to 10
mitochondrial membrane proteins) make us confident that the situation will improve further. It must be
mentioned, however, that a further difficulty in the analysis of membrane proteins is represented by their
limited abundance, even in mitochondria. In the analysis of membrane proteins by 2D electrophoresis
followed by mass spectrometry, it must be noted that peptides corresponding to segments of the
transmembrane helices can be seen in the mass spectra.
4.3. Concluding remarks
One of the major problems when dealing with organelles concerns the delimitation of what belongs to the
organelle and what does not. However, most of the so called “contaminants” which we encountered
during our study may well be at least loosely bound to the outer surface of the mitochondria. In addition,
it must be noted that  proteins devoid of transit peptides may be present both outside and inside the
mitochondria, as shown by the example of glutathione reductase [37].
The other big challenge remaining is the one of membrane proteins, as is the case for total extracts. Other,
non 2D-based approaches are probably more suitable to point out membrane proteins present in the
sample (e.g. the MUDPIT approach [38] and the ICAT approach [39]) . These peptide-based approaches
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also do not differentiate between the complete protein and its fragments, which can be quite abundant, as
shown by the number of ATP synthase fragments present on our maps. To alleviate this problem, SDS
PAGE-based approaches [8] appear more suitable. However, all these approaches do not provide easy
access to the modified forms of the proteins (see the mitofilin profile) and to the intra-sample relative
abundance of the proteins, which 2D PAGE does.
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Figure legends
Figure 1: 2D electrophoresis of mitochondrial proteins on a wide pH range.
0.2 mg mitochondrial proteins are loaded on 4mm wide IPG strips (pH interval 3-12),
in a solution containing 7M urea, 2M thiourea, 4% CHAPS, 0.4% carrier ampholytes (3-10 range) and 20
mM DTT.  Second dimension 10%T SDS gel. Detection by silver tetrathionate [20].
Figure2 : Acidic and neutral mitochondrial proteins.
The mitochondrial proteins are separated on a 4-8 linear pH gradient. Sample is loaded by in gel
rehydration. Sample solution as in figure 1. (A) 10% T SDS gel in the second dimension. (B) 12%T SDS
gel in the second dimension. The proteins are identified via their name in the SwissProt database or their
TrEmbl number (see also table 1). Red arrows: established mitochondrial proteins. Green arrows:
fragments of established mitochondrial proteins. Blue arrows: poorly characterized proteins (TrEmbl
numbers only). Black arrows: non mitochondrial proteins.
Figure3 : Basic mitochondrial proteins.
The mitochondrial proteins are separated on a 6-12 non-linear pH gradient [13]. Sample is loaded by cup
loading on the anodic side. Sample solution: 7M urea, 2M thiourea, 2% deoxyCHAPS, 0.4% carrier
ampholytes (3-10 range) 20 mM DTT and 5mM tris cyanoethyl phosphine (Molecular Probes). (A) 10%
T SDS gel in the second dimension. (B) 12%T SDS gel in the second dimension. The proteins are
identified via their name in the SwissProt database or their TrEmbl number (see also table 1). Red arrows:
established mitochondrial proteins. Green arrows: fragments of established mitochondrial proteins. Blue
arrows: poorly characterized proteins (TrEmbl numbers only). Black arrows: non mitochondrial proteins.
Orange arrow: protein present at a 0.01% level.
Figure 4: MALDI mass spectrum of trypsin-digested NUML/MLRQ subunit of complex 1 and of the
ATP-ADP exchanger.
The MALDI mass spectra of two mitochondrial proteins is shown. A: NUML/MLRQ, B: ATP-ADP
exchanger. The peptides used for identification are marked with a star.  NUML/MLRQ is a small protein
(Mw <10 kDa) while the ATP-ADP exchanger is a typical, multi transmembrane helix-containing inner
membrane protein. The peptides shown by an arrow correspond to segments of the transmembrane helices:
1219.63 (189-199), 1446.74 (81-92), 1755.99 (281-296), 1927.09 (172-188)
Code Name Accession number mass pI Sequence coverage 
(%)
D3HI 3 hydroxybutyrate dehydrogenase P31937 31 537 5.54 37
AATM Aspartate aminotransferase P00505 44 695 8.98 31
ACDS acyl CoA dehydrogenase short-chain P16219 41 721 6.15 29
ACDM Acyl-CoA dehydrogenase, medium chain specific P11310 43 643 7.02 32
ACDV Acyl-CoA dehydrogenase, very-long-chain specific P49748 66 175 7.74 32
ACON Human aconitase Q99798 82 426 6.85 11
ADT2 ADP, ATP carrier protein, ANT2 P05141 32 895 9.76 36
ATPA ATP synthase alpha chain P25705 55 209 8.28 45
ATPB ATP synthase, beta chain P06576 51 769 5.00 20
ATPD ATP synthase, delta chain P30049 15 020 4.53 ND
ATPE ATP synthase E chain AAH03679 (NCBI) 7 928 9.34 72
ATPN ATP synthase G chain O75964 11 386 9.60 33
ATPO ATP synthase oligomycin sensitivity conferral protein P48047 20 875 9.81 47
C11A Cytochrome P450 11A1 P05108 56 117 7.94 38
CH60 60 kDa heat shock protein P10809 57 963 5.24 ND
COXA Cytochrome c oxidase polypeptide Va P20674 12 513 4.88 ND
COXB Cytochrome c oxidase polypeptide Vb P10606 10 612 6,33 19
COXE Cytochrome c oxidase polypeptide VIa-liver Q02221 9 619 6,42 ND
COXG Cytochrome c oxidasepolypeptide VIb P14854 10 061 6.78 65
CYC Cytochrome c P00001 11 617 9.59 62
D3D2 3,2 trans enoyl CoA isomerase P42126 28 736 6.00 23
DHA X Antiquitin P49419 55 366 6.44 26
DHE3 Glutamate dehydrogenase P00367 56 008 6.71 51
DHSA Succinate dehydrogenase flavoprotein subunit P31040 68 012 6.25 21
DLDH Dihydrolipoamide dehydrogenase P09622 50 148 6.35 11
ECH1 Delta3,5-delta2,4-dienoyl-CoA isomerase Q13011 35 994 6.61 53
ECHA Trifunctional enzyme alpha subunit P40939 78 970 8.98 34
ECHB Trifunctional enzyme beta subunit P55084 47 485 9.24 42
ECHM Enoyl CoA hydratase, short chain P30084 28 355 5.88 53
EFTU Elongation factor Tu P49411 45 045 6.31 46
ETFA Electron transfer flavoprotein, alpha subunit P13804 35 079 8.62 67
ETFB Electron transfer flavoprotein beta subunit P38117 27 843 8.25 45
ETFD Electron transfer flavoprotein dehydrogenase Q16134 64 676 6.52 32
FUMH Fumarate hydratase P07954 50 082 6.99 32
GPDM Glycerol-3-phosphate dehydrogenase P43304 76 323 6.17 23
GR75 Stress-70 protein P38646 68 858 5.51 ND
HCD2 3-hydroxyacyl-CoA dehydrogenase type II Q99714 26 923 7.66 72
IDHA Isocitrate dehydrogenase [NAD] subunit alpha P50213 36 640 5.71 24
IVD Isovaleryl-CoA dehydrogenase P26440 43 069 6.90 20
KAD3 GTP:AMP phosphotransferase mitochondrial Q9UIJ7 25 507 9.30 31
KCRU Creatine kinase, ubiquitous mitochondrial P12532 43 080 7.31 44
MDHM Malate dehydrogenase P40926 33 000 8.54 47
MPPA Mitochondrial processing peptidase alpha subunit Q10713 55 625 5.75 32
MTX2 Metaxin 2 O75431 29 763 5.90 32
N7BM NADH-ubiquinone oxidoreductase subunit B17.2 Q9UI09 17 144 9.63 48
NB7M NADH-ubiquinone oxidoreductase B17 subunit O95139 15 358 9.63 36
NB8M NADH-ubiquinone oxidoreductase B18 subunit P17568 16 271 9.10 42
NI2M NADH-ubiquinone oxidoreductase B22 subunit Q9Y6M9 21 700 8.59 71
NI9M NADH-ubiquinone oxidoreductase B9 subunit O95167 9 279 7.98 41
NIPM NADH-ubiquinone oxidoreductase 15 kDa subunit O43920 12 386 9.29 64
NUAM NADH-ubiquinone oxidoreductase 75 kDa subunit P28331 77 053 5.36 42
NUCM NADH-ubiquinone oxidoreductase 49 kDa subunit O75306 53869 7.21 41
NUDM NADH-ubiquinone oxidoreductase 42 kDa subunit O95299 37 147 6.87 60
NUEM NADH-ubiquinone oxidoreductase 39 kDa subunit AAH15837 (NCBI) 38 899 9.70 41
NUFM NADH-ubiquinone oxidoreductase 13 kDa-B subunit Q16718 13 327 5.76 44
NUGM NADH-ubiquinone oxidoreductase 30 kDa subunit O75489 26 415 5.48 80
NUHM NADH-ubiquinone oxidoreductase 24 kDa subunit P19404 23 760 5.71 53
NUIM NADH-ubiquinone oxidoreductase 23 kDa subunit O00217 20 290 5.10 ND
NUML NADH-ubiquinone oxidoreductase MLRQ subunit O00483 9 370 9.42 76
NUPM NADH-ubiquinone oxidoreductase 19 kDa subunit, 
PGIV
P51970 19 974 7.93 47
OAT ornithine amino transferase P04181 44 808 5.72 21
ODB2 Lipoamide acyltransferase component of branched-
chain alpha-keto acid dehydrogenase complex
P11182 46 710 6.40 45
ODPA Pyruvate dehydrogenase E1 component alpha subunit, 
somatic form
P08559 40 229 6.51 49
ODPB Pyruvate dehydrogenase E1 component beta subunit P11177 35 890 5.38 ND
ODO1 2-oxoglutarate dehedrogenase E1 component Q02218 108 880 6.24 24
ORN Oligoribonuclease Q9Y3B8 26 861 6.40 19
PDX3 Thioredoxin-dependent peroxide reductase P30048 21 468 5.77 40
POR1 Voltage-dependent anion-selective channel protein 1 P21796 30 641 8.63 58
POR2 Voltage-dependent anion selective channel protein 2 P45880 38 639 6.32 41
PPCM Phosphoenolpyruvate carboxykinase Q16822 67 005 6.58 ND
PUT2 Delta-1-pyrroline 5 carboxylate dehydrogenase Q16882 59 066 6,96 42
SODM Superoxide dismutase [Mn] P04179 22 204 6.86 75
SSB Single-strand DNA-binding protein Q04837 15 195 8.24 43
THTR Thiosulfate sulfurtransferase, rhodanese Q16762 33 298 6.83 53
TRAL Heat shock protein 75 kDa Q12931 80 011 8.05
UCR1 Ubiquinol-cytochrome C reductase complex core 
protein I
P31930 49 102 5.43 46
UCR6 Ubiqinol-cytochrome C reductase complex 14 kDa 
protein
P14927 13 399 8.73 43
UCRI Ubiqinol-cytochrome C reductase iron-sulfur subunit, 
Rieske protein
P47985 21 617 6.30 35
Isocitrate dehydrogenase 2 (NADP+) Q96GT3 50 909 8.88 45
Mitochondrial thioredoxin reductase Q9H2Z5 56 204 7.24 ND
Mitofilin Q9P0V2 68 187 5.57 ND
NADH-cytochrome b5 reductase isoform Q9UHQ9 34 095 9.41 45
NADH-ubiquinone oxidoreductase B16.6 subunit Q9P0J0 16 698 8.04 41
novel AMP-binding enzyme similar to acetyl-
coenzyme A synthethase (acetate-coA ligase) 
Q9NUB1 52 592 5.85 ND
Similar to tricarboxylate carrier-like protein Q9BWM7 35 823 9.26 50
Ubiquinol-cytochrome c reductase core protein II Q9BQ05 48 443 8.74 40
Code Name Accession number mass pI Sequence coverage 
(%)
143Z 14-3-3 zeta/delta P29312 27 745 4.73 24
ACTB Actin, cytoplasmic 1 P02570 41 606 5.29 ND
ACTZ Alpha-centractin P42024 42 613 6.19 50
ALBU Serum albumin P02768 66 472 5.67 44
ANX1 Anexin I (fragment) P04083 38 787 6.64 16
ANX2 Anexin II P07355 38 472 7.56 52
AOP2 Antioxidant protein 2 P30041 24 904 6.02 ND
AOPP Putative peroxisomal antioxidant enzyme P30044 16 863 6.84 30
AR20 ARP2/3 complex 20 kDa subunit O15509 19 667 8.53 36
ARP3 Actin-like protein 3 P32391 47 371 5.61 55
COF1 Cofilin, non muscle isoform P23528 18502 8.22 38
CRAB Alpha crystallin B chain P02511 20 159 6.76 40
CYPB Peptidyl-propyl cis-trans isomerase B P23284 20 289 9.25 33
ENPL Endoplasmin P14625 90 178 4.73 51
EZRI Ezrin (fragment) P15311 69 267 5.95 18
FIBB Fibrinogen beta chain P02675 55 928 8.54 67
FLT1 Flotillin-1 O75955 47 332 7.04 49
GR78 78 kDa glucose-regulated protein P11021 70 479 5.01 51
GTP glutathione S transferase P P09211 23 224 5.44 56
H4 Histone H4 (fragment) P02304 11 236 11.36 30
K2C1 Keratin type II cytoskeletal 1 (fragment) P04264 65 886 8.16 17
PDA3 Protein disulfide isomerase A3, ERP60 P30101 57 146 5.98 51
PDA6 protein disulfide isomerase A6 Q15084 46 171 4.95 17
PDI Protein disulfide isomerase P07237 55 294 4.69 43
PDX4 Peroxiredoxin 4 Q13162 30 540 5.86 49
PERM Myeloperoxidase P05164 66 107 9.22 19
PHB Prohibitin P35232 29 804 5.57 80
PLL Lactogen, Choriomammotrophin P01243 22 308 5.33 ND
PSA7 Proteasome subunit alpha type 7 O14818 28 041 8.60 17
S110 Calpactin I light chain P08206 11 179 7.3 52
TRFE Serotransferrin P02787 75 181 6.7 43
B-Cell receptor associated protein, D-prohibitin Q99623 33 296 9.83 59
Hemoglobin alpha 1 globin chain (fragment) Q9BX83 10703 7.07 40
Human immunoglobin heavy chain variable region 
(fragment)
U00530 (OWL) 12 099 8.64 40
PI 5.3 beta 2-microglobulin Q9UDF4 11 618 6.07 55
AD025 Q9HBL7 17 190 9.58 34
BAF Barrier-to-autointegration factor O75 531 10 059 5.81 65
Brain my025 Q9H3J9 20 199 9.35 36
CG51 Protein CGI-51 Q9Y512 51 976 6.44 43
Homeotic protein Hox-4.8 (fragment) A56563 9 889 10.41 45
Hypothetical 14.5 kDa protein O95329 14 635 5.86 25
Hypothetical 23.7 kDa protein (Fragment) Q9BVM2 23 847 9.1 23
Putative transposase A AAK50868 10 182 9.79 43
SH3BGRL2-like protein Q9BPY5 12 326 6.29 70
Similar to Acetyl-CoA carboxylase beta subunit BAB74063 
(NCBI)
35 718 7.67 14
Uncharacterized hematopoietic stem/progenitor cells 
protein MDS030
Q9NZ44 17 218 9.69 34
Uncharacterized hypothalamus protein HT012, PNAS-
27
Q9NPJ3 14 960 9.23 50
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